Anteris Technologies Ltd
ASX:AVR
Anteris Technologies Ltd
ASX:AVR
Price:
8
AUD
-0.12%
Market Closed
Market Cap:
AU$329.6m
Relative Value
There is not enough data to reliably calculate the relative value of AVR.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
AVR
Relative Value
Base Case
Not Available
Multiples Across Competitors
AVR Competitors Multiples
Anteris Technologies Ltd Competitors
Anteris Technologies Ltd Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| AU |
|
Anteris Technologies Ltd
ASX:AVR
|
329.6m AUD | 46.2 | -3.7 | -3.5 | -3.5 | |
| JP |
|
Hoya Corp
TSE:7741
|
9.2T JPY | 10 | 36.6 | 26.1 | 31.3 | |
| US |
M
|
Medline Inc
NASDAQ:MDLN
|
60.6B USD | 0 | 0 | 0 | 0 | |
| CH |
|
Alcon AG
SIX:ALC
|
30.9B CHF | 4 | 38.4 | 15.8 | 30.8 | |
| DK |
|
Coloplast A/S
CSE:COLO B
|
109.4B DKK | 3.9 | 27.4 | 14.3 | 17.1 | |
| US |
|
Align Technology Inc
NASDAQ:ALGN
|
13.6B USD | 3.4 | 33.2 | 17.7 | 23 | |
| UK |
|
ConvaTec Group PLC
LSE:CTEC
|
4.7B GBP | 2.8 | 30 | 13.3 | 21.5 | |
| CA |
|
Bausch + Lomb Corp
NYSE:BLCO
|
6.3B USD | 1.3 | -20.4 | 20 | 94.2 | |
| CN |
|
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
|
40.9B CNY | 9 | 24.8 | 22.3 | 22.3 | |
| CH |
|
Ypsomed Holding AG
SIX:YPSN
|
4.1B CHF | 5.2 | 21.2 | 13.8 | 18.7 | |
| JP |
A
|
Asahi Intecc Co Ltd
TSE:7747
|
796.9B JPY | 6.4 | 52.6 | 23.1 | 33.6 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
